nodes	percent_of_prediction	percent_of_DWPC	metapath
Trisalicylate-choline—PTGS2—atherosclerosis	0.688	1	CbGaD
Trisalicylate-choline—PTGS2—leg—atherosclerosis	0.00628	0.145	CbGeAlD
Trisalicylate-choline—PTGS2—hindlimb—atherosclerosis	0.00561	0.13	CbGeAlD
Trisalicylate-choline—PTGS2—appendage—atherosclerosis	0.00481	0.111	CbGeAlD
Trisalicylate-choline—Upset stomach—Lovastatin—atherosclerosis	0.00432	0.0321	CcSEcCtD
Trisalicylate-choline—Upset stomach—Simvastatin—atherosclerosis	0.00404	0.0301	CcSEcCtD
Trisalicylate-choline—PTGS1—artery—atherosclerosis	0.0036	0.0831	CbGeAlD
Trisalicylate-choline—Heartburn—Niacin—atherosclerosis	0.00353	0.0263	CcSEcCtD
Trisalicylate-choline—Burning sensation—Niacin—atherosclerosis	0.0035	0.026	CcSEcCtD
Trisalicylate-choline—Heartburn—Pravastatin—atherosclerosis	0.00347	0.0259	CcSEcCtD
Trisalicylate-choline—PTGS2—artery—atherosclerosis	0.00344	0.0794	CbGeAlD
Trisalicylate-choline—PTGS1—endothelium—atherosclerosis	0.00304	0.0702	CbGeAlD
Trisalicylate-choline—PTGS2—endothelium—atherosclerosis	0.0029	0.0671	CbGeAlD
Trisalicylate-choline—PTGS1—blood vessel—atherosclerosis	0.0028	0.0647	CbGeAlD
Trisalicylate-choline—PTGS2—blood vessel—atherosclerosis	0.00268	0.0618	CbGeAlD
Trisalicylate-choline—Hearing impaired—Pravastatin—atherosclerosis	0.00251	0.0187	CcSEcCtD
Trisalicylate-choline—Skin exfoliation—Niacin—atherosclerosis	0.00232	0.0173	CcSEcCtD
Trisalicylate-choline—Oesophagitis—Niacin—atherosclerosis	0.00222	0.0165	CcSEcCtD
Trisalicylate-choline—Deafness—Pravastatin—atherosclerosis	0.00194	0.0145	CcSEcCtD
Trisalicylate-choline—Abdominal discomfort—Lovastatin—atherosclerosis	0.0017	0.0127	CcSEcCtD
Trisalicylate-choline—Hepatitis—Rosuvastatin—atherosclerosis	0.00168	0.0125	CcSEcCtD
Trisalicylate-choline—Abdominal discomfort—Simvastatin—atherosclerosis	0.00159	0.0119	CcSEcCtD
Trisalicylate-choline—PTGS1—connective tissue—atherosclerosis	0.00144	0.0332	CbGeAlD
Trisalicylate-choline—Hepatitis—Lovastatin—atherosclerosis	0.00142	0.0106	CcSEcCtD
Trisalicylate-choline—Magnesium salicylate—PTGS2—atherosclerosis	0.0014	0.365	CrCbGaD
Trisalicylate-choline—Hepatitis—Ezetimibe—atherosclerosis	0.00139	0.0104	CcSEcCtD
Trisalicylate-choline—PTGS2—connective tissue—atherosclerosis	0.00137	0.0317	CbGeAlD
Trisalicylate-choline—Weight increased—Pravastatin—atherosclerosis	0.00137	0.0102	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Lovastatin—atherosclerosis	0.00134	0.01	CcSEcCtD
Trisalicylate-choline—Hepatitis—Simvastatin—atherosclerosis	0.00133	0.00989	CcSEcCtD
Trisalicylate-choline—Flushing—Lovastatin—atherosclerosis	0.00132	0.00982	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Ezetimibe—atherosclerosis	0.00132	0.00981	CcSEcCtD
Trisalicylate-choline—Sweating—Niacin—atherosclerosis	0.0013	0.0097	CcSEcCtD
Trisalicylate-choline—Flushing—Ezetimibe—atherosclerosis	0.00129	0.00963	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Simvastatin—atherosclerosis	0.00126	0.00935	CcSEcCtD
Trisalicylate-choline—PTGS1—cardiovascular system—atherosclerosis	0.00125	0.0289	CbGeAlD
Trisalicylate-choline—Magnesium salicylate—ALB—atherosclerosis	0.00125	0.325	CrCbGaD
Trisalicylate-choline—Flushing—Simvastatin—atherosclerosis	0.00123	0.00918	CcSEcCtD
Trisalicylate-choline—Hepatitis—Niacin—atherosclerosis	0.00122	0.00908	CcSEcCtD
Trisalicylate-choline—Erythema—Ezetimibe—atherosclerosis	0.00121	0.00903	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Lovastatin—atherosclerosis	0.00121	0.00902	CcSEcCtD
Trisalicylate-choline—Hepatitis—Pravastatin—atherosclerosis	0.0012	0.00894	CcSEcCtD
Trisalicylate-choline—Confusional state—Rosuvastatin—atherosclerosis	0.0012	0.00894	CcSEcCtD
Trisalicylate-choline—PTGS2—cardiovascular system—atherosclerosis	0.00119	0.0276	CbGeAlD
Trisalicylate-choline—Salsalate—PTGS2—atherosclerosis	0.00119	0.31	CrCbGaD
Trisalicylate-choline—Erythema—Simvastatin—atherosclerosis	0.00116	0.00861	CcSEcCtD
Trisalicylate-choline—Tinnitus—Niacin—atherosclerosis	0.00114	0.00847	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Pravastatin—atherosclerosis	0.00114	0.00846	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Simvastatin—atherosclerosis	0.00113	0.00843	CcSEcCtD
Trisalicylate-choline—Flushing—Niacin—atherosclerosis	0.00113	0.00843	CcSEcCtD
Trisalicylate-choline—Tinnitus—Pravastatin—atherosclerosis	0.00112	0.00834	CcSEcCtD
Trisalicylate-choline—Flushing—Pravastatin—atherosclerosis	0.00111	0.0083	CcSEcCtD
Trisalicylate-choline—PTGS1—adipose tissue—atherosclerosis	0.0011	0.0255	CbGeAlD
Trisalicylate-choline—Erythema—Niacin—atherosclerosis	0.00106	0.00791	CcSEcCtD
Trisalicylate-choline—PTGS2—adipose tissue—atherosclerosis	0.00105	0.0243	CbGeAlD
Trisalicylate-choline—Dyspepsia—Rosuvastatin—atherosclerosis	0.00105	0.00781	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Pravastatin—atherosclerosis	0.00102	0.00763	CcSEcCtD
Trisalicylate-choline—Pain—Rosuvastatin—atherosclerosis	0.00102	0.00758	CcSEcCtD
Trisalicylate-choline—Constipation—Rosuvastatin—atherosclerosis	0.00102	0.00758	CcSEcCtD
Trisalicylate-choline—Confusional state—Lovastatin—atherosclerosis	0.00102	0.00758	CcSEcCtD
Trisalicylate-choline—Confusional state—Ezetimibe—atherosclerosis	0.000998	0.00743	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000981	0.00731	CcSEcCtD
Trisalicylate-choline—Anorexia—Lovastatin—atherosclerosis	0.000962	0.00716	CcSEcCtD
Trisalicylate-choline—Confusional state—Simvastatin—atherosclerosis	0.000952	0.00709	CcSEcCtD
Trisalicylate-choline—Urticaria—Rosuvastatin—atherosclerosis	0.000946	0.00704	CcSEcCtD
Trisalicylate-choline—Oedema—Simvastatin—atherosclerosis	0.000944	0.00703	CcSEcCtD
Trisalicylate-choline—Anorexia—Simvastatin—atherosclerosis	0.0009	0.0067	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Lovastatin—atherosclerosis	0.000888	0.00662	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Lovastatin—atherosclerosis	0.000877	0.00653	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Ezetimibe—atherosclerosis	0.000871	0.00649	CcSEcCtD
Trisalicylate-choline—Oedema—Niacin—atherosclerosis	0.000867	0.00645	CcSEcCtD
Trisalicylate-choline—Constipation—Lovastatin—atherosclerosis	0.000863	0.00643	CcSEcCtD
Trisalicylate-choline—Pain—Lovastatin—atherosclerosis	0.000863	0.00643	CcSEcCtD
Trisalicylate-choline—Confusional state—Pravastatin—atherosclerosis	0.00086	0.00641	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Ezetimibe—atherosclerosis	0.00086	0.00641	CcSEcCtD
Trisalicylate-choline—Oedema—Pravastatin—atherosclerosis	0.000853	0.00635	CcSEcCtD
Trisalicylate-choline—Shock—Niacin—atherosclerosis	0.000853	0.00635	CcSEcCtD
Trisalicylate-choline—Constipation—Ezetimibe—atherosclerosis	0.000846	0.0063	CcSEcCtD
Trisalicylate-choline—Pain—Ezetimibe—atherosclerosis	0.000846	0.0063	CcSEcCtD
Trisalicylate-choline—Pruritus—Rosuvastatin—atherosclerosis	0.000842	0.00627	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Niacin—atherosclerosis	0.000838	0.00624	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Lovastatin—atherosclerosis	0.000831	0.00619	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Simvastatin—atherosclerosis	0.000831	0.00619	CcSEcCtD
Trisalicylate-choline—Anorexia—Niacin—atherosclerosis	0.000826	0.00615	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Pravastatin—atherosclerosis	0.000825	0.00614	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Simvastatin—atherosclerosis	0.00082	0.00611	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Ezetimibe—atherosclerosis	0.000816	0.00607	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Rosuvastatin—atherosclerosis	0.000815	0.00607	CcSEcCtD
Trisalicylate-choline—Anorexia—Pravastatin—atherosclerosis	0.000813	0.00606	CcSEcCtD
Trisalicylate-choline—Hypotension—Niacin—atherosclerosis	0.00081	0.00603	CcSEcCtD
Trisalicylate-choline—Constipation—Simvastatin—atherosclerosis	0.000807	0.00601	CcSEcCtD
Trisalicylate-choline—Pain—Simvastatin—atherosclerosis	0.000807	0.00601	CcSEcCtD
Trisalicylate-choline—Urticaria—Lovastatin—atherosclerosis	0.000802	0.00597	CcSEcCtD
Trisalicylate-choline—Dizziness—Rosuvastatin—atherosclerosis	0.000787	0.00586	CcSEcCtD
Trisalicylate-choline—Urticaria—Ezetimibe—atherosclerosis	0.000786	0.00586	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Simvastatin—atherosclerosis	0.000778	0.00579	CcSEcCtD
Trisalicylate-choline—Somnolence—Niacin—atherosclerosis	0.00077	0.00574	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Niacin—atherosclerosis	0.000763	0.00568	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Niacin—atherosclerosis	0.000753	0.00561	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Pravastatin—atherosclerosis	0.000751	0.00559	CcSEcCtD
Trisalicylate-choline—Rash—Rosuvastatin—atherosclerosis	0.000751	0.00559	CcSEcCtD
Trisalicylate-choline—Dermatitis—Rosuvastatin—atherosclerosis	0.00075	0.00559	CcSEcCtD
Trisalicylate-choline—Urticaria—Simvastatin—atherosclerosis	0.00075	0.00558	CcSEcCtD
Trisalicylate-choline—Headache—Rosuvastatin—atherosclerosis	0.000746	0.00556	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Pravastatin—atherosclerosis	0.000742	0.00552	CcSEcCtD
Trisalicylate-choline—Pain—Niacin—atherosclerosis	0.000741	0.00552	CcSEcCtD
Trisalicylate-choline—PTGS2—liver—atherosclerosis	0.000739	0.0171	CbGeAlD
Trisalicylate-choline—Pain—Pravastatin—atherosclerosis	0.00073	0.00543	CcSEcCtD
Trisalicylate-choline—Constipation—Pravastatin—atherosclerosis	0.00073	0.00543	CcSEcCtD
Trisalicylate-choline—Pruritus—Lovastatin—atherosclerosis	0.000714	0.00532	CcSEcCtD
Trisalicylate-choline—Nausea—Rosuvastatin—atherosclerosis	0.000707	0.00527	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Pravastatin—atherosclerosis	0.000703	0.00524	CcSEcCtD
Trisalicylate-choline—Pruritus—Ezetimibe—atherosclerosis	0.0007	0.00521	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Lovastatin—atherosclerosis	0.00069	0.00514	CcSEcCtD
Trisalicylate-choline—Urticaria—Niacin—atherosclerosis	0.000688	0.00513	CcSEcCtD
Trisalicylate-choline—Urticaria—Pravastatin—atherosclerosis	0.000678	0.00505	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Ezetimibe—atherosclerosis	0.000677	0.00504	CcSEcCtD
Trisalicylate-choline—Pruritus—Simvastatin—atherosclerosis	0.000668	0.00497	CcSEcCtD
Trisalicylate-choline—Dizziness—Lovastatin—atherosclerosis	0.000667	0.00497	CcSEcCtD
Trisalicylate-choline—Dizziness—Ezetimibe—atherosclerosis	0.000654	0.00487	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Simvastatin—atherosclerosis	0.000646	0.00481	CcSEcCtD
Trisalicylate-choline—Vomiting—Lovastatin—atherosclerosis	0.000642	0.00478	CcSEcCtD
Trisalicylate-choline—Rash—Lovastatin—atherosclerosis	0.000636	0.00474	CcSEcCtD
Trisalicylate-choline—Dermatitis—Lovastatin—atherosclerosis	0.000636	0.00473	CcSEcCtD
Trisalicylate-choline—Headache—Lovastatin—atherosclerosis	0.000632	0.00471	CcSEcCtD
Trisalicylate-choline—Vomiting—Ezetimibe—atherosclerosis	0.000629	0.00469	CcSEcCtD
Trisalicylate-choline—Dizziness—Simvastatin—atherosclerosis	0.000624	0.00465	CcSEcCtD
Trisalicylate-choline—Rash—Ezetimibe—atherosclerosis	0.000624	0.00465	CcSEcCtD
Trisalicylate-choline—Dermatitis—Ezetimibe—atherosclerosis	0.000623	0.00464	CcSEcCtD
Trisalicylate-choline—Headache—Ezetimibe—atherosclerosis	0.00062	0.00462	CcSEcCtD
Trisalicylate-choline—Pruritus—Niacin—atherosclerosis	0.000613	0.00457	CcSEcCtD
Trisalicylate-choline—Pruritus—Pravastatin—atherosclerosis	0.000604	0.0045	CcSEcCtD
Trisalicylate-choline—Vomiting—Simvastatin—atherosclerosis	0.0006	0.00447	CcSEcCtD
Trisalicylate-choline—Nausea—Lovastatin—atherosclerosis	0.000599	0.00446	CcSEcCtD
Trisalicylate-choline—Rash—Simvastatin—atherosclerosis	0.000595	0.00443	CcSEcCtD
Trisalicylate-choline—Dermatitis—Simvastatin—atherosclerosis	0.000594	0.00443	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Niacin—atherosclerosis	0.000593	0.00442	CcSEcCtD
Trisalicylate-choline—Headache—Simvastatin—atherosclerosis	0.000591	0.0044	CcSEcCtD
Trisalicylate-choline—Nausea—Ezetimibe—atherosclerosis	0.000588	0.00438	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Pravastatin—atherosclerosis	0.000584	0.00435	CcSEcCtD
Trisalicylate-choline—Dizziness—Niacin—atherosclerosis	0.000573	0.00427	CcSEcCtD
Trisalicylate-choline—Dizziness—Pravastatin—atherosclerosis	0.000564	0.0042	CcSEcCtD
Trisalicylate-choline—Nausea—Simvastatin—atherosclerosis	0.000561	0.00418	CcSEcCtD
Trisalicylate-choline—Vomiting—Niacin—atherosclerosis	0.000551	0.0041	CcSEcCtD
Trisalicylate-choline—Rash—Niacin—atherosclerosis	0.000546	0.00407	CcSEcCtD
Trisalicylate-choline—Dermatitis—Niacin—atherosclerosis	0.000546	0.00407	CcSEcCtD
Trisalicylate-choline—Headache—Niacin—atherosclerosis	0.000543	0.00404	CcSEcCtD
Trisalicylate-choline—Vomiting—Pravastatin—atherosclerosis	0.000542	0.00404	CcSEcCtD
Trisalicylate-choline—Rash—Pravastatin—atherosclerosis	0.000538	0.00401	CcSEcCtD
Trisalicylate-choline—Dermatitis—Pravastatin—atherosclerosis	0.000537	0.004	CcSEcCtD
Trisalicylate-choline—Headache—Pravastatin—atherosclerosis	0.000535	0.00398	CcSEcCtD
Trisalicylate-choline—Nausea—Niacin—atherosclerosis	0.000515	0.00383	CcSEcCtD
Trisalicylate-choline—Nausea—Pravastatin—atherosclerosis	0.000507	0.00377	CcSEcCtD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CST3—atherosclerosis	0.000288	0.00221	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—atherosclerosis	0.00028	0.00215	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—INS—atherosclerosis	0.000278	0.00213	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—MTHFR—atherosclerosis	0.000277	0.00213	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	0.000275	0.00211	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—CCL2—atherosclerosis	0.000273	0.0021	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—atherosclerosis	0.000269	0.00207	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—CRP—atherosclerosis	0.000264	0.00202	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—NFKB1—atherosclerosis	0.000258	0.00198	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—APOA1—atherosclerosis	0.000255	0.00196	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—SERPINE1—atherosclerosis	0.000255	0.00196	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—ALB—atherosclerosis	0.000254	0.00195	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—F2—atherosclerosis	0.000243	0.00187	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—ICAM1—atherosclerosis	0.000242	0.00186	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	0.000238	0.00183	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	0.000238	0.00183	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	0.000237	0.00182	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—atherosclerosis	0.000234	0.0018	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—IFNG—atherosclerosis	0.000232	0.00178	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Biological oxidations—GSTM1—atherosclerosis	0.000231	0.00177	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	0.000223	0.00171	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	0.000223	0.00171	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—PTGS2—atherosclerosis	0.000223	0.00171	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—INS—atherosclerosis	0.00022	0.00169	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	0.000219	0.00168	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—atherosclerosis	0.000218	0.00168	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—CCL2—atherosclerosis	0.000217	0.00166	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	0.000215	0.00165	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—IL1B—atherosclerosis	0.000207	0.00159	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—LEP—atherosclerosis	0.000204	0.00157	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—SERPINE1—atherosclerosis	0.000202	0.00155	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—ALB—atherosclerosis	0.000202	0.00155	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—TNF—atherosclerosis	0.0002	0.00154	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—TLR4—atherosclerosis	0.0002	0.00153	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	0.000199	0.00152	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—NFKB1—atherosclerosis	0.000193	0.00148	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—ICAM1—atherosclerosis	0.000192	0.00147	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—NOS2—atherosclerosis	0.00019	0.00146	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	0.000188	0.00144	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	0.000188	0.00144	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	0.000188	0.00144	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	0.000188	0.00144	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	0.000188	0.00144	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—atherosclerosis	0.000188	0.00144	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	0.000186	0.00143	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—IFNG—atherosclerosis	0.000184	0.00141	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	0.00018	0.00138	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	0.000177	0.00136	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	0.000177	0.00136	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—SIRT1—atherosclerosis	0.000176	0.00135	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	0.000174	0.00133	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	0.000172	0.00132	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—CCL2—atherosclerosis	0.000171	0.00132	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	0.000171	0.00131	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	0.000166	0.00127	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—IL1B—atherosclerosis	0.000164	0.00126	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—LDLRAP1—atherosclerosis	0.000164	0.00126	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	0.00016	0.00123	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	0.000158	0.00121	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—atherosclerosis	0.000157	0.0012	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PLTP—atherosclerosis	0.000154	0.00118	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—NFKB1—atherosclerosis	0.000153	0.00118	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—TNF—atherosclerosis	0.00015	0.00115	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	0.000149	0.00115	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	0.000149	0.00115	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	0.000149	0.00115	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	0.000149	0.00115	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	0.000148	0.00113	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—IFNG—atherosclerosis	0.000146	0.00112	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	0.000143	0.00109	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	0.000143	0.00109	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	0.000142	0.00109	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	0.000141	0.00108	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	0.000138	0.00106	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	0.000137	0.00105	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—CXCL8—atherosclerosis	0.000136	0.00104	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ABCG8—atherosclerosis	0.000134	0.00102	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—LTA4H—atherosclerosis	0.000134	0.00102	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—atherosclerosis	0.000132	0.00102	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	0.000132	0.00101	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	0.000132	0.00101	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—IL1B—atherosclerosis	0.00013	0.000998	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—LDLRAP1—atherosclerosis	0.00013	0.000998	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	0.000127	0.000975	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	0.000124	0.000955	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—MMP9—atherosclerosis	0.000123	0.000941	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PLTP—atherosclerosis	0.000122	0.000938	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—IL6—atherosclerosis	0.000121	0.000931	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—TNF—atherosclerosis	0.000119	0.000916	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	0.000115	0.00088	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	0.000113	0.000869	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	0.000113	0.000864	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	0.000112	0.000859	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	0.000111	0.000852	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	0.000109	0.000839	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—LTA4H—atherosclerosis	0.000106	0.000813	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ABCG8—atherosclerosis	0.000106	0.000813	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ABCG1—atherosclerosis	0.000106	0.00081	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	0.000105	0.000803	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—MAPK3—atherosclerosis	0.000104	0.000799	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—TGFB1—atherosclerosis	0.000101	0.000775	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—FABP4—atherosclerosis	9.92e-05	0.000762	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—LCAT—atherosclerosis	9.92e-05	0.000762	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	9.88e-05	0.000758	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—APOA4—atherosclerosis	9.74e-05	0.000748	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—IL6—atherosclerosis	9.63e-05	0.000739	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CYP7A1—atherosclerosis	9.57e-05	0.000734	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—TNF—atherosclerosis	9.44e-05	0.000724	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—APOA4—atherosclerosis	9.23e-05	0.000709	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	9.12e-05	0.0007	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CYP27A1—atherosclerosis	8.84e-05	0.000679	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	8.81e-05	0.000676	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	8.71e-05	0.000668	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	8.49e-05	0.000652	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ALOX5AP—atherosclerosis	8.38e-05	0.000643	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ALOX15—atherosclerosis	8.38e-05	0.000643	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PLA2G2A—atherosclerosis	8.38e-05	0.000643	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—APOA2—atherosclerosis	8.38e-05	0.000643	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ABCG1—atherosclerosis	8.38e-05	0.000643	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ABCG5—atherosclerosis	8.28e-05	0.000636	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	8.27e-05	0.000635	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	8.25e-05	0.000633	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	8.11e-05	0.000622	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—LPA—atherosclerosis	8e-05	0.000614	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—APOA2—atherosclerosis	7.95e-05	0.00061	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—FABP4—atherosclerosis	7.88e-05	0.000605	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—LCAT—atherosclerosis	7.88e-05	0.000605	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—BGN—atherosclerosis	7.75e-05	0.000595	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—APOA4—atherosclerosis	7.73e-05	0.000593	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	7.69e-05	0.00059	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—APOA5—atherosclerosis	7.67e-05	0.000589	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—IL6—atherosclerosis	7.61e-05	0.000584	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CYP7A1—atherosclerosis	7.6e-05	0.000583	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	7.49e-05	0.000575	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	7.45e-05	0.000572	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PLA2G1B—atherosclerosis	7.38e-05	0.000567	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—BGN—atherosclerosis	7.34e-05	0.000564	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	7.3e-05	0.00056	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	7.24e-05	0.000556	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	7.23e-05	0.000555	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	7.21e-05	0.000554	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ALOX5—atherosclerosis	7.13e-05	0.000547	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	7.08e-05	0.000544	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CYP27A1—atherosclerosis	7.02e-05	0.000539	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	6.91e-05	0.00053	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	6.87e-05	0.000527	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	6.74e-05	0.000518	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—APOA2—atherosclerosis	6.66e-05	0.000511	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ALOX15—atherosclerosis	6.66e-05	0.000511	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ALOX5AP—atherosclerosis	6.66e-05	0.000511	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PLA2G2A—atherosclerosis	6.66e-05	0.000511	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	6.59e-05	0.000505	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ABCG5—atherosclerosis	6.57e-05	0.000505	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	6.57e-05	0.000504	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	6.42e-05	0.000493	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CST3—atherosclerosis	6.4e-05	0.000491	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—NAMPT—atherosclerosis	6.39e-05	0.000491	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	6.36e-05	0.000488	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—LIPC—atherosclerosis	6.35e-05	0.000488	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—LPA—atherosclerosis	6.35e-05	0.000487	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—APOC3—atherosclerosis	6.32e-05	0.000485	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—LDLR—atherosclerosis	6.28e-05	0.000482	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—BGN—atherosclerosis	6.15e-05	0.000472	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CETP—atherosclerosis	6.13e-05	0.00047	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	6.11e-05	0.000469	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—APOA5—atherosclerosis	6.09e-05	0.000467	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—NAMPT—atherosclerosis	6.06e-05	0.000465	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—APOC3—atherosclerosis	5.99e-05	0.000459	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—LDLR—atherosclerosis	5.95e-05	0.000457	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	5.91e-05	0.000454	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—SCARB1—atherosclerosis	5.87e-05	0.000451	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PLA2G1B—atherosclerosis	5.86e-05	0.00045	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	5.79e-05	0.000445	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—HSPA1B—atherosclerosis	5.75e-05	0.000441	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	5.74e-05	0.000441	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	5.73e-05	0.00044	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	5.72e-05	0.000439	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ALOX5—atherosclerosis	5.66e-05	0.000434	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—NCF1—atherosclerosis	5.57e-05	0.000427	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—HMGCR—atherosclerosis	5.54e-05	0.000425	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CYBA—atherosclerosis	5.23e-05	0.000402	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	5.23e-05	0.000401	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PARP1—atherosclerosis	5.12e-05	0.000393	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—NAMPT—atherosclerosis	5.08e-05	0.00039	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	5.05e-05	0.000387	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—LIPC—atherosclerosis	5.04e-05	0.000387	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—APOC3—atherosclerosis	5.01e-05	0.000385	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	5e-05	0.000384	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—LDLR—atherosclerosis	4.98e-05	0.000382	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ABCA1—atherosclerosis	4.94e-05	0.000379	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CETP—atherosclerosis	4.87e-05	0.000373	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	4.78e-05	0.000367	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SCARB1—atherosclerosis	4.66e-05	0.000358	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	4.54e-05	0.000348	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—HMGCR—atherosclerosis	4.4e-05	0.000338	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—HMOX1—atherosclerosis	4.24e-05	0.000325	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—APOB—atherosclerosis	4.06e-05	0.000312	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GSTM1—atherosclerosis	3.95e-05	0.000303	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ABCA1—atherosclerosis	3.92e-05	0.000301	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—LPL—atherosclerosis	3.88e-05	0.000298	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—APOB—atherosclerosis	3.85e-05	0.000295	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GPX1—atherosclerosis	3.78e-05	0.00029	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CD36—atherosclerosis	3.68e-05	0.000283	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—LPL—atherosclerosis	3.68e-05	0.000282	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PRKCG—atherosclerosis	3.57e-05	0.000274	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—MTHFR—atherosclerosis	3.49e-05	0.000268	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PPARA—atherosclerosis	3.43e-05	0.000263	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—HMOX1—atherosclerosis	3.37e-05	0.000258	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—AGT—atherosclerosis	3.32e-05	0.000255	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—MTHFR—atherosclerosis	3.31e-05	0.000254	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—APOE—atherosclerosis	3.25e-05	0.000249	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—APOB—atherosclerosis	3.22e-05	0.000247	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PDGFB—atherosclerosis	3.22e-05	0.000247	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CAV1—atherosclerosis	3.22e-05	0.000247	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—APOA1—atherosclerosis	3.21e-05	0.000247	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GSTM1—atherosclerosis	3.14e-05	0.000241	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—APOE—atherosclerosis	3.08e-05	0.000236	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—LPL—atherosclerosis	3.08e-05	0.000236	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CAV1—atherosclerosis	3.05e-05	0.000234	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—APOA1—atherosclerosis	3.05e-05	0.000234	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GPX1—atherosclerosis	3e-05	0.00023	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PIK3CG—atherosclerosis	2.93e-05	0.000225	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CD36—atherosclerosis	2.92e-05	0.000224	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—NOS2—atherosclerosis	2.87e-05	0.00022	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PPARG—atherosclerosis	2.83e-05	0.000217	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—INS—atherosclerosis	2.78e-05	0.000213	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—MTHFR—atherosclerosis	2.77e-05	0.000213	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PPARA—atherosclerosis	2.72e-05	0.000209	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—AGT—atherosclerosis	2.63e-05	0.000202	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—INS—atherosclerosis	2.63e-05	0.000202	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—APOE—atherosclerosis	2.58e-05	0.000198	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CAV1—atherosclerosis	2.56e-05	0.000196	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—APOA1—atherosclerosis	2.55e-05	0.000196	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ALB—atherosclerosis	2.55e-05	0.000195	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—NOS3—atherosclerosis	2.44e-05	0.000187	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—SERPINE1—atherosclerosis	2.42e-05	0.000186	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PIK3CG—atherosclerosis	2.33e-05	0.000179	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—NOS3—atherosclerosis	2.31e-05	0.000177	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PPARG—atherosclerosis	2.25e-05	0.000172	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PTGS2—atherosclerosis	2.23e-05	0.000171	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—INS—atherosclerosis	2.2e-05	0.000169	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ALB—atherosclerosis	2.02e-05	0.000155	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—NOS3—atherosclerosis	1.93e-05	0.000148	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—STAT3—atherosclerosis	1.65e-05	0.000126	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—MAPK3—atherosclerosis	1.57e-05	0.000121	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—TGFB1—atherosclerosis	1.53e-05	0.000117	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—IL6—atherosclerosis	1.15e-05	8.83e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—AKT1—atherosclerosis	1.12e-05	8.59e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—AKT1—atherosclerosis	1.06e-05	8.14e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—AKT1—atherosclerosis	8.89e-06	6.82e-05	CbGpPWpGaD
